Surrozen SRZN
NASDAQ SRZN
$32.64 +0.64 (+2.00%)
At close: Nov 10, 2026 · 4:00 PM EST

Surrozen (SRZN) Other Operating Expenses (2020)

Updated

Surrozen (SRZN) reported Other Operating Expenses of $40,000 for Q4 2023, down 97.3% from the prior quarter.

Analysis

Surrozen (SRZN) Other Operating Expenses (2020) Analysis & Trends

For FY2023, Surrozen posted Other Operating Expenses of $2.75 million.

  • The Q4 2023 figure ranks as the lowest quarterly Other Operating Expenses since Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Surrozen 384.30 Mn -14.29 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 -10.40 Mn
API Access

Surrozen Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=SRZN&period=max&api_key=YOUR_API_KEY